Bibliography
- Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999;15:394-9
- Dotani MI, Elnicki DM, Jain AC, et al. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 2000;86:1128-30. A6
- Wilhelmi M, Winterhalter M, Fischer S, et al. Massive postoperative rhabdomyolysis following combined CABG/abdominal aortic replacement: a possible association with HMG-CoA reductase inhibitors. Cardiovasc Drugs Ther 2002;16:471-5
- Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003;107:1848-51
- Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004;291:2092-9
- Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004;39:967-75
- Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009;361:980-9
- Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009;249:921-6
- O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 2005;45:336-42
- Chopra V, Eagle KA. Perioperative mischief: the price of academic misconduct. Am J Med 2012;125:953-5
- Chopra V, Wesorick DH, Sussman JB, et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis. Arch Surg 2012;147:181-9
- Irwin M, Chan W, Wong G. Perioperative statin therapy. Expert Opin Pharmacother 2013;14(7):831-42
- Report on the 2012 follow-up investigation of possible breaches of academic integrity. Erasmus MC Follow-up Investigation Committee. 2012. Available from: http://cardiobrief.files.wordpress.com/2012/10/integrity-report-2012-10-english-translation.pdf [Last accessed 03/21/2013]
- Heyer EJ, Mergeche JL, Bruce SS, et al. Statins reduce neurologic injury in asymptomatic carotid endarterectomy patients. Stroke 2013;44(4):1150-2
- Kuhn EW, Liakopoulos OJ, Deppe AC, et al. Rosuvastatin reloading before cardiac surgery with cardiopulmonary bypass. Eur Surg Res 2013;50:1-13
- Liakopoulos OJ, Kuhn EW, Slottosch I, et al. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev 2012;4:CD008493
- Bhave PD, Goldman LE, Vittinghoff E, et al. Statin use and postoperative atrial fibrillation after major noncardiac surgery. Heart Rhythm 2012;9:163-9
- Trezzi M, Blackstone EH, Sun Z, et al. Statin therapy is associated with fewer infections after cardiac operations. Ann Thorac Surg 2013;95(3):892-900
- Neilipovitz DT, Bryson GL, Taljaard M. STAR VaS–short term atorvastatin regime for vasculopathic subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Can J Anaesth 2012;59:527-37
- Hinz J, Gehoff P, Schotola H, et al. Hemodynamic effects of peri-operative statin therapy in on-pump cardiac surgery patients. J Cardiothorac Surg 2012;7:39
- Gui D, Spada PL, De Gaetano A, et al. Hypocholesterolemia and risk of death in the critically ill surgical patient. Intensive Care Med 1996;22:790-4
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207
- Park SJ, Choi JH, Cho SJ, et al. Comparison of transthoracic echocardiography with N-terminal pro-brain natriuretic peptide as a tool for risk stratification of patients undergoing major noncardiac surgery. Korean Circ J 2011;41:505-11